Abstract
In studies on the relation between indoor mold exposure and symptoms/disease, the exposure should be described in terms of biomass and not viability. This paper reviews field studies in which (1--> 3)-ss-d-glucan was measured as a marker of biomass and was related to the extent of symptoms and measures of inflammation among exposed subjects. Increased levels of (1-->3)-ss-d-glucan were related to an increased extent of symptoms and markers of inflammation. The data suggest that (1-->3)-ss-d-glucan can be used as a risk marker in indoor environments.